AXT, Inc. Q4 FY2025 Earnings Call

· Earnings call transcript and AI-powered summary

Financial Performance Highlights

  • Revenue: $23.0 million in Q4 2025, down from $28.0 million in Q3 2025 and $25.1 million in Q4 2024. Product breakdown: Indium Phosphide $8.0M (data center focus), Gallium Arsenide $7.0M, Germanium $0.231M, Raw materials JV $7.6M. Geographic: Asia Pacific 81.5%, Europe 17.5%, North America 1%.
  • Gross Margin: Non-GAAP 21.5% in Q4 2025 (vs. 22.6% in Q3 2025, improved from 18.0% in Q4 2024). GAAP 20.9% (vs. 22.3% Q3 2025, 17.6% Q4 2024).
  • Operating Expenses: Non-GAAP $7.8M in Q4 2025 (vs. $6.5M Q3 2025 due to prior favorable adjustments; down from $9.8M Q4 2024). GAAP $8.8M (vs. $7.3M Q3, $10.6M Q4 2024).
  • Operating Loss: Non-GAAP $2.6M in Q4 2025 (vs. $0.384M Q3 2025; improved from $5.4M Q4 2024). GAAP loss $3.8M (vs. $1.1M Q3, $6.2M Q4 2024).
  • Net Loss: Non-GAAP $2.6M or $0.06/share (vs. $1.2M or $0.02/share Q3 2025; improved from $4.2M or $0.10/share Q4 2024). GAAP $3.6M or $0.08/share (vs. $1.9M or $0.04/share Q3 2025; improved from $5.1M or $0.12/share Q4 2024).
  • Balance Sheet: Cash, equivalents & investments rose to $128.4M (up $97.2M from Q3, primarily from $93.9M public stock offering). Inventory up $4M to $81.7M. Depreciation $2.3M; stock comp $1.3M. Shares outstanding: 44.7M basic.

Business & Market Context

Professional feature The full AI summary covers key highlights, financial performance and analyst Q&A.
Operator: Good afternoon, everyone, and welcome to AXT's Fourth Quarter 2025 Financial Conference Call. Leading the call today is Dr. Morris Young, Chief Executive Officer; and Gary Fischer, Chief Financial Officer. In addition, Tim Bettles, VP of Business Development, will be participating in the Q&A portion of the call. My name is Audra, and I will be your coordinator today. I would now like to turn the call over to Leslie Green, Investor Relations for AXT. Please go ahead. Leslie Green: Thank you, Audra, and good afternoon, everyone. Before we begin, I would like to remind you that during the course of this conference call, including comments made in response to your questions, we will provide projections or make other forward-looking statements regarding, among other things, the future financial performance of the company, market conditions and trends, emerging applications using chips or devices fabricated on our substrates, our product mix, global economic and political conditions, including trade tariffs and import and export restrictions, ability to obtain China export permits, timing of receipt of export permits, our plan to list our subsidiary, Tongmei in China, our ability to increase orders in succeeding quarters to control costs and expenses, to improve manufacturing yields and efficiencies or to utilize our manufacturing capacity. We wish to caution you that such statements deal with future events, are based on management's current expectations and are subject t
Professional feature The full transcript includes every speaker turn.